Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
VentriPoint Diagnostics Ltd (TSE:VPT)
TSXV:VPT
RESEARCH TOOLSreports
Holding TSE:VPT?
Track your performance easily
VPT Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.14 - C$0.36
Previous CloseC$0.21
Volume16.30K
Average Volume (3M)105.06K
Market Cap
C$33.01M
Enterprise ValueC$32.98M
Total Cash (Recent Filing)C$375.01K
Total Debt (Recent Filing)C$350.69K
Price to Earnings (P/E)―
Beta0.11
Next Earnings
Aug 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding157,182,655
10 Day Avg. Volume126,616
30 Day Avg. Volume105,061
Standard Deviation0.35
R-Squared0.00746
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)21.50
Price to Sales (P/S)495.76
Price to Cash Flow (P/CF)-8.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
VentriPoint Diagnostics News
PremiumCompany Announcements
Ventripoint Launches U.S. Sales Program for AI SolutionsPremiumCompany Announcements
Ventripoint Diagnostics Reveals New Convertible Debenture Offering
PremiumCompany Announcements
Ventripoint Earns EU CE Mark for AI Heart Tech
PremiumCompany Announcements
Ventripoint Diagnostics Closes First Private Placement Tranche
PremiumCompany Announcements
Ventripoint Extends and Upsizes Private Placement Offerings
PremiumCompany Announcements
Ventripoint Aims for EU Approval with AI Heart Tech
PremiumCompany Announcements
VentriPoint Passes Key Audits, Eyes EU Market Expansion
PremiumCompany Announcements
Ventripoint’s AI Cardiac Imaging Revolutionizes Heart CareOptions Prices
Currently, No data available
---
Ownership Overview
15.03% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
84.97% Public Companies and
Individual Investors
VPT FAQ
What was VentriPoint Diagnostics Ltd’s price range in the past 12 months?
VentriPoint Diagnostics Ltd lowest stock price was C$0.14 and its highest was C$0.36 in the past 12 months.
What is VentriPoint Diagnostics Ltd’s market cap?
Currently, no data Available
When is VentriPoint Diagnostics Ltd’s upcoming earnings report date?
VentriPoint Diagnostics Ltd’s upcoming earnings report date is Aug 28, 2024 which is 86 days ago.
How were VentriPoint Diagnostics Ltd’s earnings last quarter?
Currently, no data Available
Is VentriPoint Diagnostics Ltd overvalued?
According to Wall Street analysts VentriPoint Diagnostics Ltd’s price is currently Overvalued.
Does VentriPoint Diagnostics Ltd pay dividends?
VentriPoint Diagnostics Ltd does not currently pay dividends.
What is VentriPoint Diagnostics Ltd’s EPS estimate?
VentriPoint Diagnostics Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VentriPoint Diagnostics Ltd have?
VentriPoint Diagnostics Ltd has 157,182,650 shares outstanding.
What happened to VentriPoint Diagnostics Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VentriPoint Diagnostics Ltd?
Currently, no hedge funds are holding shares in TSE:VPT
---
VentriPoint Diagnostics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth C$71.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.50%
12-Months-Change
Fundamentals
Return on Equity
-383.91%
Trailing 12-Months
Asset Growth
-82.41%
Trailing 12-Months
Company Description
VentriPoint Diagnostics Ltd
VentriPoint Diagnostics Ltd is a Canada based medical device company. It is primarily engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure and normal hearts. It sells its products in Canada and internationally.
---
Technical Analysis
---